Article
Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer
16 May 2018
Abstract excerpt
Despite the progress made in molecular and clinical research, patients with advanced-stage gastric cancer (GC) have a bad prognosis and very low survival rates. Furthermore, it is challenging to find the complex molecular mechanisms that are involved in the development of GC, its progression, and its resistance to therapy. The interactions of chemokines, also known as chemotactic cytokines, with their receptors...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
